Abstract
Background
We developed a novel, injectable and decellularized human peripheral nerve-based scaffold, named Micronized Human Neural Tissue (hMINT), designed to be used as a supportive matrix for stem cell transplantation in the context of spinal cord injury (SCI).
Materials and methods
Human donated sciatic nerves were micronized at liquid nitrogen temperature prior to decellularization using 3 different procedures of various harshness. hMINT were characterized in terms of particle size, DNA, sulfated glycosaminoglycans (sGAG) and growth factors content. To test the biocompatibility and bioactivity of the various preparations, we used a type of mesenchymal stromal cells (MSCs), termed MIAMI cells, which were placed in contact with hMINT to monitor cell attachment by confocal microscopy and gene expression by RT-qPCR in vitro.
Results
The content of DNA, sGAG and growth factors left in the product after processing was highly dependent on the decellularization procedure used. We demonstrated that hMINT are biocompatible and promoted the attachment and long-term survival of MIAMI cells in vitro. Finally, combination with hMINT increased MIAMI cells mRNA expression of pro-survival and anti-inflammatory factors. Importantly, the strongest bioactivity on MIAMI cells was observed with the hMINT decellularized using the mildest decellularization procedure, therefore emphasizing the importance of achieving an adequate decellularization without losing the hMINT’s bioactivity.
Perspectives and clinical significance
The capacity of hMINT/stem cells to facilitate protection of injured neural tissue, promote axon re-growth and improve functional recovery will be tested in an animal model of SCI and other neurodegenerative disorders in the future.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Bamber NI, Li H, Lu X, Oudega M, Aebischer P, Xu XM (2001) Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur J Neurosci 13(2):257–268
Barzilay R, Kan I, Ben-Zur T, Bulvik S, Melamed E, Offen D (2008) Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols. Stem Cells Dev 17(3):547–554
Boido M, Garbossa D, Fontanella M, Ducati A, Vercelli A (2012) Mesenchymal stem cell transplantation reduces glial cyst and improves functional outcome following spinal cord compression. World Neurosurg 81(1):183–190
Bregman BS, Coumans JV, Dai HN, Kuhn PL, Lynskey J, McAtee M, Sandhu F (2002) Transplants and neurotrophic factors increase regeneration and recovery of function after spinal cord injury. Prog Brain Res 137:257–273
Brohlin M, Mahay D, Novikov LN, Terenghi G, Wiberg M, Shawcross SG, Novikova LN (2009) Characterisation of human mesenchymal stem cells following differentiation into Schwann cell-like cells. Neurosci Res 64(1):41–49
Cho SR, Kim YR, Kang HS, Yim SH, Park CI, Min YH, Lee BH, Shin JC, Lim JB (2009) Functional recovery after the transplantation of neurally differentiated mesenchymal stem cells derived from bone barrow in a rat model of spinal cord injury. Cell Transplant 18(12):1359–1368
Cizkova D, Rosocha J, Vanicky I, Jergova S, Cizek M (2006) Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat. Cell Mol Neurobiol 26(7–8):1167–1180
Curtis K, Gomez L, Rios C, Garbayo E, Raval A, Perez-Pinzon M, Schiller P (2010) EF1alpha and RPL13a represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal stem cells. BMC Mol Biol 11(1):1–15
Delcroix GJ, Curtis KM, Schiller PC, Montero-Menei CN (2010) EGF and bFGF pre-treatment enhances neural specification and the response to neuronal commitment of MIAMI cells. Differentiation 80(4–5):213–227
Delcroix GJ, Garbayo E, Sindji L, Thomas O, Vanpouille-Box C, Schiller PC, Montero-Menei CN (2011) The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats. Biomaterials 32(6):1560–1573
Delcroix GJ, Kaimrajh DN, Baria D, Cooper S, Reiner T, Latta L, D’Ippolito G, Schiller PC, Temple HT (2013) Histologic, biomechanical, and biological evaluation of fan-folded iliotibial band allografts for anterior cruciate ligament reconstruction. Arthroscopy 29:756–765
D’Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC (2004) Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117(Pt 14):2971–2981
Garbayo E, Raval AP, Curtis KM, Della-Morte D, Gomez LA, D’Ippolito G, Reiner T, Perez-Stable C, Howard GA, Perez-Pinzon MA, Montero-Menei CN, Schiller PC (2011) Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers. J Neurochem 119(5):972–988
Guo JS, Zeng YS, Li HB, Huang WL, Liu RY, Li XB, Ding Y, Wu LZ, Cai DZ (2007) Cotransplant of neural stem cells and NT-3 gene modified Schwann cells promote the recovery of transected spinal cord injury. Spinal Cord 45(1):15–24
Haggerty AE, Oudega M (2013) Biomaterials for spinal cord repair. Neurosci Bull 29:445–459
Hudson TW, Liu SY, Schmidt CE (2004a) Engineering an improved acellular nerve graft via optimized chemical processing. Tissue Eng 10(9–10):1346–1358
Hudson TW, Zawko S, Deister C, Lundy S, Hu CY, Lee K, Schmidt CE (2004b) Optimized acellular nerve graft is immunologically tolerated and supports regeneration. Tissue Eng 10(11–12):1641–1651
Keilhoff G, Goihl A, Langnase K, Fansa H, Wolf G (2006a) Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells. Eur J Cell Biol 85(1):11–24
Keilhoff G, Stang F, Goihl A, Wolf G, Fansa H (2006b) Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination. Cell Mol Neurobiol 26(7–8):1235–1252
Kubinova S, Sykova E (2012) Biomaterials combined with cell therapy for treatment of spinal cord injury. Regen Med 7(2):207–224
Li C, Zhang X, Cao R, Yu B, Liang H, Zhou M, Li D, Wang Y, Liu E (2012) Allografts of the acellular sciatic nerve and brain-derived neurotrophic factor repair spinal cord injury in adult rats. PLoS ONE 7(8):e42813
Novikova LN, Brohlin M, Kingham PJ, Novikov LN, Wiberg M (2011) Neuroprotective and growth-promoting effects of bone marrow stromal cells after cervical spinal cord injury in adult rats. Cytotherapy 13(7):873–887
Onose G, Anghelescu A, Muresanu DF, Padure L, Haras MA, Chendreanu CO, Onose LV, Mirea A, Ciurea AV, El Masri WS, von Wild KR (2009) A review of published reports on neuroprotection in spinal cord injury. Spinal Cord 47(10):716–726
Osaka M, Honmou O, Murakami T, Nonaka T, Houkin K, Hamada H, Kocsis JD (2010) Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res 1343:226–235
Park HW, Lim MJ, Jung H, Lee SP, Paik KS, Chang MS (2010) Human mesenchymal stem cell-derived Schwann cell-like cells exhibit neurotrophic effects, via distinct growth factor production, in a model of spinal cord injury. Glia 58(9):1118–1132
Park JH, Kim DY, Sung IY, Choi GH, Jeon MH, Kim KK, Jeon SR (2012) Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans. Neurosurgery 70(5):1238–1247
Perale G, Giordano C, Bianco F, Rossi F, Tunesi M, Daniele F, Crivelli F, Matteoli M, Masi M (2011) Hydrogel for cell housing in the brain and in the spinal cord. Int J Artif Organs 34(3):295–303
Sondell M, Lundborg G, Kanje M (1998) Regeneration of the rat sciatic nerve into allografts made acellular through chemical extraction. Brain Res 795(1–2):44–54
Tatard VM, D’Ippolito G, Diabira S, Valeyev A, Hackman J, McCarthy M, Bouckenooghe T, Menei P, Montero-Menei CN, Schiller PC (2007) Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons. Bone 40(2):360–373
Vaquero J, Zurita M (2009) Bone marrow stromal cells for spinal cord repair: a challenge for contemporary neurobiology. Histol Histopathol 24(1):107–116
Volpato FZ, Fuhrmann T, Migliaresi C, Hutmacher DW, Dalton PD (2013) Using extracellular matrix for regenerative medicine in the spinal cord. Biomaterials 34:4945–4955
Wislet-Gendebien S, Hans G, Leprince P, Rigo JM, Moonen G, Rogister B (2005a) Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells 23(3):392–402
Wislet-Gendebien S, Wautier F, Leprince P, Rogister B (2005b) Astrocytic and neuronal fate of mesenchymal stem cells expressing nestin. Brain Res Bull 68(1–2):95–102
Yang J, Lou Q, Huang R, Shen L, Chen Z (2008) Dorsal root ganglion neurons induce transdifferentiation of mesenchymal stem cells along a Schwann cell lineage. Neurosci Lett 445(3):246–251
Zhou Z, Chen Y, Zhang H, Min S, Yu B, He B, Jin A (2013) Comparison of mesenchymal stem cells from human bone marrow and adipose tissue for the treatment of spinal cord injury. Cytotherapy 15:434–448
Acknowledgements
We are grateful to Laurence Sindji (MINT Inserm U1066, University of Angers, France) for particle sizing experiments as well as to Justin Kallman, Jeffrey Davila, Cassandra Anton and Laura Varela for the technical assistance provided during hMINT processing.
Funding
This work was funded by the University of Miami Tissue Bank. This study was also supported by the Miami VA Healthcare System Geriatric Research Education and Clinical Center and used resources and facilities of VINCI, VA HSR RES 13-457. The views expressed are those of the authors and not those of the Geriatric Research Education and Clinical Center or VINCI.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors have no conflict of interest to disclose. HTT is the medical director at Vivex Biologics, Inc. The other authors have no relevant financial or non-financial interests to disclose.
Human and animal Participants
All human tissues were recovered within the University of Miami Tissue Bank following rules and regulations set by the American Association for Tissue Banking (AATB).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Delcroix, G.JR., Hackett, A., Schiller, P.C. et al. Characterization of three washing/decellularization procedures for the production of bioactive human micronized neural tissue (hMINT). Cell Tissue Bank 24, 693–703 (2023). https://doi.org/10.1007/s10561-023-10075-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-023-10075-3